PHARMACOR POSACONAZOLE posaconazole 100 mg modified release tablet blister pack Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

pharmacor posaconazole posaconazole 100 mg modified release tablet blister pack

pharmacor pty ltd - posaconazole, quantity: 100 mg - tablet, enteric coated - excipient ingredients: hypromellose acetate succinate; magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica; croscarmellose sodium; hyprolose; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - posaconazole is indicated for use in the treatment of the following invasive fungal infections in patients 13 years of age or older: invasive aspergillosis in patients intolerant of, or with disease that is refractory to, alternative therapy. fusariosis, zygomycosis, coccidioidomycosis, chromoblastomycosis, and mycetoma in patients intolerant of, or with disease that is refractory to, alternative therapy.,posaconazole is also indicated for the: prophylaxis of invasive fungal infections among patients 13 years of age and older, who are at high risk of developing these infections, such as patients with prolonged neutropenia or haematopoietic stem cell transplant (hsct) recipients.

AKM POSACONAZOLE posaconazole 100 mg modified release tablet blister pack Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

akm posaconazole posaconazole 100 mg modified release tablet blister pack

pharmacor pty ltd - posaconazole, quantity: 100 mg - tablet, enteric coated - excipient ingredients: magnesium stearate; croscarmellose sodium; hyprolose; microcrystalline cellulose; hypromellose acetate succinate; colloidal anhydrous silica; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - posaconazole is indicated for use in the treatment of the following invasive fungal infections in patients 13 years of age or older: invasive aspergillosis in patients intolerant of, or with disease that is refractory to, alternative therapy. fusariosis, zygomycosis, coccidioidomycosis, chromoblastomycosis, and mycetoma in patients intolerant of, or with disease that is refractory to, alternative therapy.,posaconazole is also indicated for the: prophylaxis of invasive fungal infections among patients 13 years of age and older, who are at high risk of developing these infections, such as patients with prolonged neutropenia or haematopoietic stem cell transplant (hsct) recipients.

AXOFIL posaconazole 100 mg modified release tablet bottle pack Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

axofil posaconazole 100 mg modified release tablet bottle pack

pharmacor pty ltd - posaconazole, quantity: 100 mg - tablet, enteric coated - excipient ingredients: hyprolose; microcrystalline cellulose; colloidal anhydrous silica; croscarmellose sodium; hypromellose acetate succinate; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - posaconazole is indicated for use in the treatment of the following invasive fungal infections in patients 13 years of age or older: invasive aspergillosis in patients intolerant of, or with disease that is refractory to, alternative therapy. fusariosis, zygomycosis, coccidioidomycosis, chromoblastomycosis, and mycetoma in patients intolerant of, or with disease that is refractory to, alternative therapy.,posaconazole is also indicated for the: prophylaxis of invasive fungal infections among patients 13 years of age and older, who are at high risk of developing these infections, such as patients with prolonged neutropenia or haematopoietic stem cell transplant (hsct) recipients.

PHARMACOR POSACONAZOLE posaconazole 100 mg modified release tablet bottle pack Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

pharmacor posaconazole posaconazole 100 mg modified release tablet bottle pack

pharmacor pty ltd - posaconazole, quantity: 100 mg - tablet, enteric coated - excipient ingredients: magnesium stearate; croscarmellose sodium; hypromellose acetate succinate; hyprolose; microcrystalline cellulose; colloidal anhydrous silica; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - posaconazole is indicated for use in the treatment of the following invasive fungal infections in patients 13 years of age or older: invasive aspergillosis in patients intolerant of, or with disease that is refractory to, alternative therapy. fusariosis, zygomycosis, coccidioidomycosis, chromoblastomycosis, and mycetoma in patients intolerant of, or with disease that is refractory to, alternative therapy.,posaconazole is also indicated for the: prophylaxis of invasive fungal infections among patients 13 years of age and older, who are at high risk of developing these infections, such as patients with prolonged neutropenia or haematopoietic stem cell transplant (hsct) recipients.

AKM POSACONAZOLE posaconazole 100 mg modified release tablet bottle pack Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

akm posaconazole posaconazole 100 mg modified release tablet bottle pack

pharmacor pty ltd - posaconazole, quantity: 100 mg - tablet, enteric coated - excipient ingredients: hyprolose; magnesium stearate; croscarmellose sodium; colloidal anhydrous silica; microcrystalline cellulose; hypromellose acetate succinate; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - posaconazole is indicated for use in the treatment of the following invasive fungal infections in patients 13 years of age or older: invasive aspergillosis in patients intolerant of, or with disease that is refractory to, alternative therapy. fusariosis, zygomycosis, coccidioidomycosis, chromoblastomycosis, and mycetoma in patients intolerant of, or with disease that is refractory to, alternative therapy.,posaconazole is also indicated for the: prophylaxis of invasive fungal infections among patients 13 years of age and older, who are at high risk of developing these infections, such as patients with prolonged neutropenia or haematopoietic stem cell transplant (hsct) recipients.

Isothesia NXT New Zealand - Ingliż - Ministry for Primary Industries

isothesia nxt

provet nz pty ltd - isoflurane - isoflurane 100 % - anaesthetic

Vinyl examination/treatment glove, non-powdered Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

vinyl examination/treatment glove, non-powdered

shield right pty ltd - 47176 - vinyl examination/treatment glove, non-powdered - a disposable hand protective device made out of vinyl, used as a protective barrier between examiner and patient.

ACCENSI BIFENTHRIN 100 EC INSECTICIDE/MITICIDE Awstralja - Ingliż - APVMA (Australian Pesticides and Veterinary Medicines Authority)

accensi bifenthrin 100 ec insecticide/miticide

accensi pty ltd - bifenthrin; liquid hydrocarbon - emulsifiable concentrate - bifenthrin pyrethroid active 100.0 g/l; liquid hydrocarbon solvent other 763.0 g/l - miticide - apricot | banana | barley | canola | citrus | clover | cotton | faba bean | field pea | grape | lucerne | lucerne seed crop | lu - apple dimpling bug - c. liebknechti | banana rust thrip | banana weevil borer | blue oat or pea mite | brown pasture looper | bryobia mite - bryobia spp. | carpophilus beetle | citrus leaf-eating weevil | corn earworm | cotton budworm or bollworm | false wireworm | fig longicorn | green mirid bug | greenhouse whitefly | longtailed mealy bug | native budworm or bollworm | native budworm or bollworm - larvae | pasture webworm | redlegged earth mite | strawberry spider mite | sugarcane wireworm - agrypnus spp. | sugarcane wireworm - agrypnus variabilis | tomato russet mite | two spotted mite | vegetable weevil | banana spider mite | campylomma livida | corn earworm | cotton bollworm | desiantha weevil (wa) | dihammus vastator | heliothis | native bollworm | red legged earth mite | red spider mite | spider mite | tobacco budworm | tomato grub | tomato mite (47236) | two-spotted mite | two-spotted spider mite | yellow mirid

Carbimazole 5 mg Tablets Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

carbimazole 5 mg tablets

essential-healthcare ltd. - carbimazole - tablet - 5 milligram(s) - sulfur-containing imidazole derivatives; carbimazole

Carbimazole 20 mg Tablets Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

carbimazole 20 mg tablets

essential-healthcare ltd. - carbimazole - tablet - 20 milligram(s) - sulfur-containing imidazole derivatives; carbimazole